A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors 
Better For You Wellness Enters Definitive Agreement to Acquire Mango Moi, LLC
BFYW is Expecting to Close First of Many Contemplated M&A TransactionsColumbus, Ohio--(Newsfile Corp. - May 2, 2022) - Better For...
Tinley’s Acquires 100% of Lakewood Libations, Inc.
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - May 2, 2022) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX:...
Vapotherm to Report First Quarter 2022 Financial Results
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and...
Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
On Its Anniversary, the Inventor of Measure-through Motion and Low Perfusion™ Pulse Oximetry Introduces the First Health Watch to Offer...
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
Blue Spark Technologies Announces Appointment of John DeFord, Ph.D. to its Board of Directors
The new board member will provide extensive expertise to expand the TempTraq® remote patient monitoring platform CLEVELAND--(BUSINESS WIRE)--Blue Spark Technologies...
Skyway Capital Markets Advises SPAC on $85 Million Medical Technology Merger
TAMPA, Fla.--(BUSINESS WIRE)--Skyway Capital Markets, LLC (“Skyway”) is pleased to announce the merger of SeaStar Medical, Inc. (“SeaStar Medical”), a...
Extended SpagoPix Patent Protection in USA
LUND, SWEDEN / ACCESSWIRE / May 2, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical AB (publ) has received notice from the...
Kala Pharmaceuticals to Present Clinical Data for KPI-012, its Mesenchymal Stem Cell Secretome Product, for the Treatment of PCED at the 2022 ARVO Annual Meeting
-- Data Demonstrate Rapid and Complete Wound Healing, with Six of Eight (75%) Patients Achieving Complete Healing within Four Weeks;...
Brain Cancer Canada funds Canada’s first genomics technology for rapid and precise brain tumour diagnostics
TORONTO, May 01, 2022 (GLOBE NEWSWIRE) -- Today marks the first day of Brain Cancer Awareness month. On this day...
Ascendis Pharma A/S to Present New Endocrinology Results at Four Medical Meetings in May
New data highlights include: - Phase 3 open-label extension study data for growth hormone-deficient children treated for 2.5 years with TransConTM...
Total number of voting rights and share capital in GN Store Nord
In accordance with Section 32 of the Danish Capital Markets Act, GN Store Nord is required to publish the total...
Oticon Wins Two Prestigious Red Dot Global Design Awards 2022
Oticon demonstrates its unwavering prowess in product design, achieving not one, but two internationally recognised awards for good design for...
The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes
Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not...
Saniona publishes its Annual Report for 2021
PRESS RELEASE April 30, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that the...
Tarsus to Host Webcast to Review Topline Results from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
Theralase Release FY2021 Audited Financial Statements
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
Correction: Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22%...
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S.ROCKVILLE,...
Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer
ORGOVYX® is the first and only oral androgen deprivation therapy for advanced hormone-sensitive prostate cancer in EuropeMyovant expects to secure...